Advertisement

International Urology and Nephrology

, Volume 37, Issue 3, pp 507–510 | Cite as

Long Term Follow Up of Men with Alfuzosin who Voided Successfully Following Acute Urinary Retention*

  • V. Palit
  • T. Shah
  • C. S. Biyani
  • Y. Elmasry
  • R. Sarkar
  • G. M. Flannigan
  • R. Puri
Article

Abstract

Introduction Acute urinary retention (AUR) is one of the commonest causes of admission in urology ward and successful voiding with α-blockers has been reported. However, long-term efficacy of Alfuzosin, following an episode of AUR is lacking. This is a continuation of our earlier reported study. We report the results of a 4 year follow-up on patients who were on Alfuzosin SR 5 mg BD, following resumption of voiding after an episode of AUR. Patients and methods A total of 33 patients voided successfully following AUR in our original study. These patients continued on Alfuzosin SR 5 mg BD and were assessed at 2 and 4 years. Symptomatic assessment was performed with IPSS and QOL symptom score and objective assessment was with urinary flow rate and post void residual volume. Patients who continued to deteriorate symptomatically and objectively or developed further AUR were listed for surgery. Results Out of 33 patients, 28 patients were followed up at 2 years (three patients died due to various medical reasons and two did not attend for follow-up). Nineteen patients (68%) underwent transurethral resection of prostate (TURP) for severe lower urinary tract symptom (LUTS) .The mean peak flow rate at 2 years was 8.4 ml/s and the mean residual volume was 112 ml. Ten patients attended for follow up at 4 years. The mean flow rate was 5.17 ml/s and the mean post-void residual volume was 101 ml. Four patients underwent TURP for severe outflow symptoms. At 4 years follow up 24 out of 30 patients (80%) on Alfuzosin needed TURP. Conclusions These data do not support the long term use of α-blockers in patients who voided successfully after acute urinary retention.

Keywords

Acute urinary retention α-Blockers Trial without catheter 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jacobsen, SJ, Jacobsen, DJ, Girman, CJ,  et al. 1997Natural history of prostatism: risk factors for acute urinary retentionJ Urol158481487PubMedGoogle Scholar
  2. 2.
    Pickard, R, Emberton, M, Neal, DE. 1998The management of men with acute urinary retentionBrit J Urol81712720PubMedGoogle Scholar
  3. 3.
    Chilton, CP, Morgan, RJ, England, HR,  et al. 1978A critical evaluation of the results of transurethral resection of the prostateBr J Urol50542546PubMedCrossRefGoogle Scholar
  4. 4.
    Mebust, WK, Holtgrewe, HL, Cockett, ATK, Peters, PC. 1989Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of participating institutions evaluating 3885 patientsJ Urol141243247PubMedGoogle Scholar
  5. 5.
    Lim, KB, Wong, MYC, Foo, KT. 1999The outcome of trial of catheter after acute retention of urineAnn Acad Med28516518Google Scholar
  6. 6.
    Shah, T, Palit, V, Biyani, S,  et al. 2002Randomised, placebo controlled. Double blind study of Alfuzosin SR in patients undergoing trial without catheter following acute urinary retentionEur Urol42329332CrossRefPubMedGoogle Scholar
  7. 7.
    Hartung, R 2001Do α-blockers prevent the occurrence of acute urinary retention?Eur Urol391318PubMedGoogle Scholar
  8. 8.
    Jardin A, Bensadoun H, Attali P, and the BPH-ALF group: Alfuzosin for the treatment of benign prostatic hypertrophy. Lancet 1991; 337: 1457–1461.Google Scholar
  9. 9.
    Martorana, G, Giberti, C, Silverio, F,  et al. 1997Effects of short term treatment with the α1 blocker Alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasiaEur Urol324753PubMedGoogle Scholar
  10. 10.
    Mcneill, SA. 2004The role of alpha-blockers in the management of Acute Urinary Retention caused by benign prostatic obstructionEur Urol45325332Google Scholar
  11. 11.
    McNeill, SA, Daruwala, PD, Mitchell, IDC,  et al. 1999Sustained-release Alfuzosin and trial without catheter after urinary retention: a prospective, placebo-controlled trialBJUI84622627CrossRefGoogle Scholar
  12. 12.
    Mcneill, SA. 2001Does acute urinary retention respond to alpha-blockers alone?Eur Urol39712PubMedGoogle Scholar
  13. 13.
    McConnell, JD, Roehrborn, GC,  et al. 2003The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign Prostatic hyperplasiaNew Engl J Med34923872398CrossRefPubMedGoogle Scholar
  14. 14.
    Mcneill, A, Naadimthu, A, Hargreave, T 2003the ALFAUR study group Alfuzosin 10mg once daily in the management of acute urinary retention-preliminary results of alfaur studyEur Urol Suppl275Abstract 291CrossRefGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • V. Palit
    • 1
  • T. Shah
    • 1
  • C. S. Biyani
    • 1
  • Y. Elmasry
    • 1
  • R. Sarkar
    • 1
  • G. M. Flannigan
    • 1
  • R. Puri
    • 1
  1. 1.Urology officeBradford Hospitals NHS Trust, St. Lukes HospitalBradfordUK

Personalised recommendations